banner








The Chandran Laboratory’s scientific expertise is in the genetic and molecular epidemiology of psoriatic disease (PsD; psoriasis and psoriatic arthritis [PsA]). This lifelong disease strikes patients in their youth, and is currently incurable, leading to progressive joint damage, functional limitation, poor mental health, reduced quality of life, and increased mortality. Our translational research program focuses on understanding PsD pathobiology with particular emphasis on untargeted global discovery of novel biomarkers and drug targets using high throughput and augmented intelligence technologies.


Biomarkers

In using proteomic analyses of synovial fluid, skin and blood samples of patients with psoriatic disease, we have identified a number of proteins that are markers for psoriatic arthritis or can distinguish psoriatic arthritis patients from patients with psoriasis ...
more
Omics

In using proteomic analyses of synovial fluid, skin and blood samples of patients with psoriatic disease, we have identified a number of proteins that are markers for psoriatic arthritis or distinguished between PsA and PsC ...
more
Functional studies

We are currently looking at protein and peptide expression in the synovial fluid and investigating the proteolytically-regulated receptor activation in synovial fluid and blood-derived cells of patients with psoriatic arthritis and other inflammatory arthritides ...
more
Drug discovery

With a focus to evaluate our biomarker and functional findings as potential drug targets we have been using cell culture and tissue explant models reminiscent of psoriatic disease, to screen for potential therapeutic compounds ...
more

Latest news


Applying Precision Medicine to Psoriatic Disease. (Thursday, July 12th, 2018 - BMO Education and Conference Centre).

Second news. xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. X xxxx x ...

Third news. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x x.

Fourth news. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x ...

Fifth news. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x. Xxxx xxxx x xxxx x.


Archived news




Department of Rheumatology
University Health Network
Contact information